Page last updated: 2024-10-24

celecoxib and Hemolysis

celecoxib has been researched along with Hemolysis in 6 studies

Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.

Research Excerpts

ExcerptRelevanceReference
"This paper aims at demonstrating silk fibroin nanoparticles (SFNs) promote anti-inflammatory properties of celecoxib (CXB) or curcumin (CUR), and could be exploited for osteoarthritis (OA) treatment."7.91Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis. ( Bari, E; Catenacci, L; Crivelli, B; Faragò, S; Mocchi, M; Perteghella, S; Prina-Mello, A; Sorrenti, M; Torre, ML; Tripodo, G, 2019)
"This paper aims at demonstrating silk fibroin nanoparticles (SFNs) promote anti-inflammatory properties of celecoxib (CXB) or curcumin (CUR), and could be exploited for osteoarthritis (OA) treatment."3.91Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis. ( Bari, E; Catenacci, L; Crivelli, B; Faragò, S; Mocchi, M; Perteghella, S; Prina-Mello, A; Sorrenti, M; Torre, ML; Tripodo, G, 2019)
" All synthesized new compounds along with compound III as a parent compound and Celecoxib as a reference, were assessed for their antiinflammatory activity both in-vivo and in-vitro using the formalin-induced hind paw edema method and inhibition of albumin denaturation and Red Blood Cells (RBCs) membrane stabilization, respectively."3.88Synthesis, In-vivo and In-vitro Anti-inflammatory Evaluation of some Novel Coumarin Derivatives. ( Al-Wabli, R; El-Haggar, R; Fouad, M, 2018)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, F1
Yi, Y1
Sun, P1
Zhang, D1
Dube, PN1
Bule, SS1
Mokale, SN1
Kumbhare, MR1
Dighe, PR1
Ushir, YV1
Al-Wabli, R1
Fouad, M1
El-Haggar, R1
Crivelli, B1
Bari, E1
Perteghella, S1
Catenacci, L1
Sorrenti, M1
Mocchi, M1
Faragò, S1
Tripodo, G1
Prina-Mello, A1
Torre, ML1
Lupescu, A1
Bissinger, R1
Jilani, K1
Lang, F1
Arai, Y1
Tanaka, K1
Ushijima, H1
Tomisato, W1
Tsutsumi, S1
Aburaya, M1
Hoshino, T1
Yokomizo, K1
Suzuki, K1
Katsu, T1
Tsuchiya, T1
Mizushima, T1

Other Studies

6 other studies available for celecoxib and Hemolysis

ArticleYear
Synthesis, in vitro inhibitory activity towards COX-2 and haemolytic activity of derivatives of esculentoside A.
    Bioorganic & medicinal chemistry letters, 2007, Dec-01, Volume: 17, Issue:23

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cyclooxygenase 2; Cyclooxygenase 2 Inhi

2007
Synthesis and biologic evaluation of substituted 5-methyl-2-phenyl-1H-pyrazol-3(2H)-one derivatives as selective COX-2 inhibitors: molecular docking study.
    Chemical biology & drug design, 2014, Volume: 84, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Binding Sites; Carrageenan; Catalytic Domain; Cyclo

2014
Synthesis, In-vivo and In-vitro Anti-inflammatory Evaluation of some Novel Coumarin Derivatives.
    Anti-inflammatory & anti-allergy agents in medicinal chemistry, 2018, Volume: 17, Issue:2

    Topics: Albumins; Animals; Anti-Inflammatory Agents; Celecoxib; Coumarins; Disease Models, Animal; Dose-Resp

2018
Silk fibroin nanoparticles for celecoxib and curcumin delivery: ROS-scavenging and anti-inflammatory activities in an in vitro model of osteoarthritis.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2019, Volume: 137

    Topics: Anti-Inflammatory Agents; Antioxidants; Celecoxib; Cell Survival; Cells, Cultured; Curcumin; Drug De

2019
Triggering of suicidal erythrocyte death by celecoxib.
    Toxins, 2013, Sep-10, Volume: 5, Issue:9

    Topics: Apoptosis; Calcium; Celecoxib; Cell Size; Cells, Cultured; Cyclooxygenase 2 Inhibitors; Erythrocytes

2013
Low direct cytotoxicity of nabumetone on gastric mucosal cells.
    Digestive diseases and sciences, 2005, Volume: 50, Issue:9

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Celecoxib; Cell C

2005